Simpson Thacher Represents La Quinta in Initial Public Offering and Debt Refinancing

The Firm represented La Quinta Holdings Inc. in connection with its initial public offering of 43,987,500 shares of common stock (including shares sold pursuant to the underwriters’ option to purchase additional shares) at a public offering price of $17.00 per share. La Quinta’s common stock began trading on the New York Stock Exchange under the ticker symbol “LQ” on April 9, 2014. The underwriting syndicate was led by J.P. Morgan and Morgan Stanley.

More >>

Tags:  Simpson Thacher & Bartlett LLP

Bauer Performance Sports Acquires BRG Sports for $330 Million

Paul, Weiss client Bauer Performance Sports Ltd., a leading developer and manufacturer of high performance sports equipment and apparel, announced the official closing with Easton-Bell Sports, now officially known as BRG Sports, Inc., to acquire the Easton Baseball/Softball business for $330 million in an all-cash transaction. The acquisition greatly enhances the company’s performance sports platform by adding Easton, the world’s leading and most iconic diamond sports brand, to the other strong brands in the BPS portfolio, including Bauer, Mission, Maverik, Cascade, Inaria and Combat. It also adds valuable intellectual property to BPS and provides a significant counter-seasonal business to the company’s existing revenue stream.

More >>

Weil Advises Eli Lilly in $5.4B Acquisition of Novartis Animal Health

A Weil team is advising Eli Lilly and Company in its agreement to acquire Novartis Animal Health for approximately $5.4 billion in an all-cash transaction that is expected to close by the end of the first quarter of 2015, subject to regulatory and other customary closing conditions. Upon completion of the acquisition, Elanco, Lilly’s own animal health business, will be the second-largest animal health company in terms of global revenue. More >>

Tags:  Weil, Gotshal & Manges, LLP

Shearman & Sterling Advises Algerian Fonds National d’Investissement (FNI) on Acquisition of 51% Stake in Orascom Telecom Algérie (Djezzy)

After three years of highly complex negotiations, Algerian Fonds National d’Investissement (FNI), a strategic investment fund controlled by the Algerian State, signed a Share Purchase Agreement related to the acquisition of a 51% stake in Orascom Télécom Algérie SpA (“OTA” or “Djezzy”) from Global Telecom Holding SAE (“GTH,” formerly Orascom Telecom Holding SAE), a majority-owned subsidiary of Russian company VimpelCom Ltd, for a purchase consideration of US$2.643 billion.

FNI and GTH also agreed to enter into a Shareholders Agreement (“the Shareholders Agreement”), which will become effective upon the closing of the transaction, and will govern the parties’ relationships as shareholders in OTA.

Djezzy is the leading mobile network operator in Algeria. The company offers a wide range of services, pre-paid or post-paid, encompassing voice, data and multimedia. Djezzy’s 2013 revenue amounted to US$1.796 billion, with a 2013 EBITDA of US$1.055 billion. As of December 31, 2013, the company’s network included over 17 million subscribers, which makes it the leading mobile phone operator in the country.

More >>

Tags:  Shearman & Sterling LLP

Cooley Advises Stratasys on Acquisition of Solid Concepts

Cooley LLP announced today that it acted as US counsel to Stratasys Ltd. on its acquisition of Solid Concepts. Meitar Liquornik Geva Leshem Tal was Israeli counsel to Stratasys, one of the world’s leading 3D printing companies. Stratasys manufactures 3D printers and materials that create prototypes and manufactured goods directly from 3D CAD (computer aided design) files or other 3D content. Stratasys will also acquire Texas-based Harvest Technologies.

More >>

Tags:  Cooley LLP

Sichenzia Ross Friedman Ference LLP Advises J.P. Turner & Company, L.L.C on $ 2.5 million Private Placement of X2 Bio Systems, Inc..

New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented J.P. Turner & Company as sole Placement Agent  in a $2.5  million private placement of X2 Bio systems, Inc., a privately held Seattle based science and technology company which is developing the first complete solution for assessing sport brain injuries.  The underwriting was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of $2.5 million of Units consisting of 6% convertible promissory notes and common stock purchase warrants. The Sichenzia Ross team was led by partners Gregory Sichenzia and David Manno. More >>

Willkie Advises Victory Capital Management in Acquisition of Munder Capital Management

Willkie client Victory Capital Management Inc. announced that it has entered into an agreement to acquire Munder Capital management. The deal combines two strong Midwest-based investment management firms with multi-boutique business models. The new independent investment advisory firm, which will be headquartered in Cleveland, Ohio, will have over $37 billion of assets under management and a diversified lineup of investment offerings.

More >>

Tags:  Willkie Farr & Gallagher LLP